Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment
- PMID: 11526241
- PMCID: PMC56965
- DOI: 10.1073/pnas.171610498
Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment
Abstract
Invasion and dissemination of well-differentiated carcinomas are often associated with loss of epithelial differentiation and gain of mesenchyme-like capabilities of the tumor cells at the invasive front. However, when comparing central areas of primary colorectal carcinomas and corresponding metastases, we again found the same differentiated epithelial growth patterns. These characteristic phenotypic changes were associated with distinct expression patterns of beta-catenin, the main oncogenic protein in colorectal carcinomas, and E-cadherin. Nuclear beta-catenin was found in dedifferentiated mesenchyme-like tumor cells at the invasive front, but strikingly, as in central areas of the primary tumors, was localized to the membrane and cytoplasm in polarized epithelial tumor cells in the metastases. This expression pattern was accompanied by changes in E-cadherin expression and proliferative activity. On the basis of these data, we postulate that an important driving force for progression of well-differentiated colorectal carcinomas is the specific environment, initiating two transient phenotypic transition processes by modulating intracellular beta-catenin distribution in tumor cells.
Figures





Similar articles
-
[The Rudolf Virchow Prize 2001. The role of the oncoprotein beta-catenin ni the progression of colorectal cancers].Verh Dtsch Ges Pathol. 2001;85:243-9. Verh Dtsch Ges Pathol. 2001. PMID: 11894405 German.
-
Patterns of alpha- and beta-catenin and E-cadherin expression in colorectal adenomas and carcinomas.J Pathol. 1997 Jul;182(3):325-30. doi: 10.1002/(SICI)1096-9896(199707)182:3<325::AID-PATH865>3.0.CO;2-Y. J Pathol. 1997. PMID: 9349236
-
[beta-Catenin induces invasive growth by activating matrix metalloproteinases in colorectal carcinoma].Verh Dtsch Ges Pathol. 2000;84:175-81. Verh Dtsch Ges Pathol. 2000. PMID: 11217438 German.
-
The interactions of APC, E-cadherin and beta-catenin in tumour development and progression.J Pathol. 1997 Jun;182(2):128-37. doi: 10.1002/(SICI)1096-9896(199706)182:2<128::AID-PATH839>3.0.CO;2-Q. J Pathol. 1997. PMID: 9274521 Review.
-
Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin.Cells Tissues Organs. 2005;179(1-2):56-65. doi: 10.1159/000084509. Cells Tissues Organs. 2005. PMID: 15942193 Review.
Cited by
-
Epithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbance.Cancer Sci. 2013 Jan;104(1):28-35. doi: 10.1111/cas.12074. Epub 2012 Dec 31. Cancer Sci. 2013. PMID: 23181983 Free PMC article. Review.
-
OSR1 phosphorylates the Smad2/3 linker region and induces TGF-β1 autocrine to promote EMT and metastasis in breast cancer.Oncogene. 2021 Jan;40(1):68-84. doi: 10.1038/s41388-020-01499-2. Epub 2020 Oct 13. Oncogene. 2021. PMID: 33051597
-
Functional Enrichment Analysis of Tumor Microenvironment-Driven Molecular Alterations That Facilitate Epithelial-to-Mesenchymal Transition and Distant Metastasis.Bioinform Biol Insights. 2024 Feb 4;18:11779322241227722. doi: 10.1177/11779322241227722. eCollection 2024. Bioinform Biol Insights. 2024. PMID: 38318286 Free PMC article.
-
Probing the Fifty Shades of EMT in Metastasis.Trends Cancer. 2016 Feb;2(2):65-67. doi: 10.1016/j.trecan.2016.01.001. Trends Cancer. 2016. PMID: 27042694 Free PMC article.
-
Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.Oncotarget. 2015 Sep 15;6(27):24488-98. doi: 10.18632/oncotarget.4177. Oncotarget. 2015. PMID: 26041890 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous